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Global causes of maternal death: a WHO systematic analysis
Lale Say, Doris Chou, Alison Gemmill, Özge Tunçalp, Ann-Beth Moller, Jane Daniels, A Metin Gülmezoglu, Marleen Temmerman, Leontine Alkema

Summary
Background Data for the causes of maternal deaths are needed to inform policies to improve maternal health.
We developed and analysed global, regional, and subregional estimates of the causes of maternal death during
2003–09, with a novel method, updating the previous WHO systematic review.
Methods We searched specialised and general bibliographic databases for articles published between between Jan 1,
2003, and Dec 31, 2012, for research data, with no language restrictions, and the WHO mortality database for vital
registration data. On the basis of prespeciﬁed inclusion criteria, we analysed causes of maternal death from datasets.
We aggregated country level estimates to report estimates of causes of death by Millennium Development Goal
regions and worldwide, for main and subcauses of death categories with a Bayesian hierarchical model.
Findings We identiﬁed 23 eligible studies (published 2003–12). We included 417 datasets from 115 countries
comprising 60 799 deaths in the analysis. About 73% (1 771 000 of 2 443 000) of all maternal deaths between 2003 and
2009 were due to direct obstetric causes and deaths due to indirect causes accounted for 27·5% (672 000, 95% UI
19·7–37·5) of all deaths. Haemorrhage accounted for 27·1% (661 000, 19·9–36·2), hypertensive disorders 14·0%
(343 000, 11·1–17·4), and sepsis 10·7% (261 000, 5·9–18·6) of maternal deaths. The rest of deaths were due to abortion
(7·9% [193 000], 4·7–13·2), embolism (3·2% [78 000], 1·8–5·5), and all other direct causes of death (9·6% [235 000],
6·5–14·3). Regional estimates varied substantially.
Interpretation Between 2003 and 2009, haemorrhage, hypertensive disorders, and sepsis were responsible for more
than half of maternal deaths worldwide. More than a quarter of deaths were attributable to indirect causes. These
analyses should inform the prioritisation of health policies, programmes, and funding to reduce maternal deaths at
regional and global levels. Further eﬀorts are needed to improve the availability and quality of data related to maternal
mortality.
Funding USAID, the US Fund for UNICEF through a grant from the Bill & Melinda Gates Foundation to CHERG, and
The UNDP/UNFPA/UNICEF/WHO/The World Bank Special Programme of Research, Development, and Research
Training in Human Reproduction (HRP), Department of Reproductive Health and Research.
Copyright ©2014 World Health Organization; licensee Elsevier. This is an Open Access article published without any
waiver of WHO’s privileges and immunities under international law, convention, or agreement. This article should
not be reproduced for use in association with the promotion of commercial products, services, or any legal entity.
There should be no suggestion that WHO endorses any speciﬁc organisation or products. The use of the WHO logo
is not permitted. This notice should be preserved along with the article’s original URL.

Introduction
An estimated 287 000 maternal deaths occured worldwide
in 2010, most of which were in low-income and middleincome countries and were avoidable.1 Reduction of
maternal mortality has long been a global health priority
and is a target in the UN Millennium Development Goals
(MDG) framework2 and a key concern of the Global
Strategy for Women’s and Children’s Health launched by
the UN Secretary-General in September, 2010.3 To reach the
target of the ﬁfth MDG, a 75% decrease in maternal
mortality ratio (the number of maternal deaths per 100 000
livebirths) between 1990 and 2015 is needed. Some progress
towards this target has been reported, especially in the past
decade,1,4–6 but further improvements are needed.
A key requirement for further advances in reduction of
maternal deaths is to understand the causes of deaths for
eﬀective policy and health programme decisions. The
deﬁnition of maternal mortality (“the death of a woman

whilst pregnant or within 42 days of delivery or termination
of pregnancy, from any cause related to, or aggravated by
pregnancy or its management, but excluding deaths from
incidental or accidental causes”7) allows the identiﬁcation
of maternal deaths on the basis of their causes, as either
direct or indirect. However, collection of routine and
complete information about causes of maternal death has
not been possible because of inadequacies of data
collection and absence of vital registration systems in
most countries. The ﬁrst systematic analysis of all available
published scientiﬁc literature and government reports on
causes of maternal death was published in 2006, and
provided an overall picture of the contribution of diﬀerent
causes to the burden of maternal deaths. In 2006, we
reported haemorrhage and hypertensive disorders as the
leading causes of maternal mortality in developing
regions.8 More recently, the Global Burden of Disease
(GBD) study9 provided estimates of maternal causes of
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death for the main direct causes as part of the analysis of
all causes of death.
We analysed global, regional, and subregional estimates
of the causes of maternal death during 2003–09, with a
novel method. This period was chosen to avoid overlap
with the previous review that covered 1998–2002.8 The
study period did not include reported deaths from more
recent years to ensure increased comparability across
countries; more recent data were not available for most
countries, especially within the WHO mortality database
that includes vital registration datasets made available by
the countries. We also elaborated for the ﬁrst time further
breakdown of main cause of death categories, and provided
cause of death estimates for disorders that are clinically
important—eg, antepartum and postpartum haemorrhage.

Methods
Search strategy and selection criteria
We used the International Classiﬁcation of Diseases
(ICD, 10th edition) deﬁnition of maternal mortality,7 and
included maternal deaths reported during 2003–09, and
generated regional estimates for the ten MDG regions.10
We searched for data for causes of maternal death from
two distinct sources. We used vital registration datasets
from the WHO mortality database, made available by
countries.11 We deemed vital registration data as good
quality if the completeness of death registration in the
population older than 5 years was more than 85% and
the proportion of ill-deﬁned causes of death (coded as
R99) were less than 20%. Details of how we assessed
completeness and coverage of vital registration data by
WHO mortality statistics are described elsewhere.1

338 datapoints from 79
countries (vital registration)

56 datapoints from 32
countries (government
reports, special surveys,
and confidential enquiries)

Bibliographic databases

11 051 citations (2003–08)
435 titles for review
14 853 citations (2008–10)
220 titles for review
24 275 citations (2010–12)
222 titles for review

23 datapoints from 11 countries

We also did a literature search of bibliographic
databases by adapting a previously described search
strategy12 (appendix). Two reviewers (ABM and DC)
initially screened the citations identiﬁed by the searches
on the basis of their titles and abstracts. The full text of
the article was obtained if both reviewers judged a
citation as potentially eligible and a third reviewer (JPD)
adjudicated on discrepant opinions. A second round of
screening of the full reports was done in the same way.
Additionally, we identiﬁed government reports including
cause-of-death information by hand searching WHO
regional databases, websites of Ministries of Health and
National Statistical Oﬃces, and archives of relevant
reports received by WHO. We considered studies
identiﬁed through the literature search and governmental
reports for inclusion if they reported data for the causes
of maternal mortality between Jan 1, 2003, and Dec 31,
2009. We excluded studies that contained data before
2003 that could not be disaggregated from after 2002
data and with midpoint of the data collection period
before 2003. In line with the 2006 review, we also
excluded studies reporting fewer than 25 deaths or fewer
than four major categories of death.8 Lastly, we excluded
studies in which more than 25% of deaths did not have a
cause assigned. We considered subnational studies for
inclusion only if investigators explicitly reported
methods and if the maternal deaths that they reported
were deemed to be representative of the population they
pertained to. We included studies from health facilities
or institutions only if the institutional birth rate was
greater than or equal to 50% in that setting during
2003–09. The institutional birth rate was based on the
national country reported ﬁgure derived from sources
such as Demographic and Health Surveys, Multiple
Indicator Cluster Surveys, and national health statistical
reports.
If diﬀerent data sources overlapped for a country
period, we included only one data source, and national
data took precedence over data from subnational levels in
the following order: national enquiries, vital registration,
and nationally representative surveys of maternal deaths.
Thus, although countries might have had only one
source of data for any particular year, more than one
source might have been included in the entire study
period 2003–09.

Data extraction and classiﬁcation of maternal deaths
62 378 deaths reported in 417 datapoints from 115 countries

1579 deaths excluded because of
unascertained cause of death

60 799 deaths reported in 417 datapoints from 115 countries

Figure 1: Study proﬁle
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Data extraction from studies and reports was done by one
reviewer (ABM) and independently checked on the form
by another (JPD or DC). ICD-10 codes were used to classify
causes of maternal death (appendix). Data using ICD-9
codes were converted to ICD-10 codes with the WHO
ICD-10 Translator.13 We excluded vital registration data
from Russia, Kazakhstan, Belarus, and Ukraine reported
with ICD 10-1 because accurate assignment of deaths to
the equivalent ICD-10 codes or analytical pregnancy or
obstetric categories was not possible. We assigned
www.thelancet.com/lancetgh Vol 2 June 2014
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research study data equivalent ICD-10 codes by matching
the closest diagnosis. When data presented were
ambiguous, contradictory, or could not be disaggregated,
we tried to contact the author for clariﬁcation. If this was
not successful, we used the consensus view of two of the
authors (JPD, DC). Maternal deaths assigned to unknown
as a cause of death were excluded from the analysis.
For analysis purposes, we grouped maternal causes of
death into seven main categories of direct and indirect
causes: abortion, embolism, obstetric haemorrhage,
hypertensive disorders, pregnancy-related sepsis, other
direct causes, and indirect causes. The abortion category
includes induced abortion, miscarriage, and ectopic
pregnancy. We deﬁned the category of indirect maternal
deaths in line with the WHO application of ICD-10
(ICD-MM) to deaths during pregnancy, childbirth, and the
puerperium.14 ICD-MM was published to enable a
standardised grouping of causes of death and to avoid
presentation of highly aggregated data in diﬀering
classiﬁcation groups, complicating the task of data
comparability. The broad ICD-MM categories were further
subdivided. The category haemorrhage was divided into
subcategories of antenatal, intrapartum, and postpartum
haemorrhage; other direct causes were subcategorised into
complications of delivery, obstructed labour, and all other
direct causes. Indirect causes of death were subcategorised
into medical disorders, HIV-related maternal deaths, and
all other indirect causes.

A

Global CoDD

ABO
EMB
HEM
HYP
SEP
DIR
IND

B

Regional CoDDs
ABO
EMB

HEM
HYP

SEP
DIR

IND

Dev

N Africa

SSA

E Asia

S Asia

Statistical analysis
For every country, we estimated the causes of death
distribution on the basis of country-speciﬁc data (if
available) and the regional causes of death distribution
with a Bayesian hierarchical model. We estimated all
causes and subcauses hierarchically except for the
proportion of HIV/AIDS indirect deaths, which we
modelled separately because of the dependence of the
proportion on the severity of the HIV/AIDS epidemic in
the country.
To construct country-speciﬁc HIV/AIDS-removed causes
of death distribution, we divided countries into three
categories on the basis of data availability and data quality.
We divided countries with recorded causes of death
distribution into categories A and B, and combined
countries without any data in group C.15 Category A
included all countries with good quality and complete vital
registration data, where the sample of maternal deaths (for
which the recorded causes of death distribution was
obtained) was deemed to be representative of the total
number of maternal deaths for the country during the
period of interest. For countries in category B for which
vital registration data might have been available but not
considered good quality, we assumed that the estimated
causes of death distribution from the recorded samples
were not necessarily representative of the causes of death
distribution of all maternal deaths in the period of interest
(appendix p 7).
www.thelancet.com/lancetgh Vol 2 June 2014
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Figure 2: Estimates for main causes of death worldwide
Point estimates are shown by bars (and squares) and 95% uncertainty
intervals are shown by the horizontal lines. CoDD=cause of death distribution.
ABO=abortion. EMB=embolism. HEM=haemorrhage. HYP=hypertension.
SEP=sepsis. DIR=direct causes. IND=indirect causes. Dev=developed regions.
N Africa=northern Africa. SSA=sub-Saharan Africa. E Asia=eastern Asia.
S Asia=southern Asia. SE Asia=southeastern Asia. W Asia=western Asia.
CC Asia=Caucasus and central Asia. LAC=Latin America and the Caribbean.
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We used the Bayesian hierarchical model for the HIV/
AIDS-removed cause of death distribution to exchange
information about these distributions between countries.
With this method, the estimates in countries with scarce
information were informed by the typical experience in
the region, which is the HIV/AIDS-removed causes of
death distribution that is unweighted by the countryspeciﬁc total maternal deaths envelopes in the region.
Additionally, in the hierarchical model, typical regional
patterns in groups with scarce information were informed
by patterns in other regions. For countries in group C, the
cause of death distribution estimates were given by the
typical regional estimates, and we assessed uncertainty on
the basis of the estimated variability in, and correlation
structure of, country-speciﬁc causes of death distribution
within regions. For countries in group A with good quality
vital registration data, the cause of death distribution was
estimated from the recorded causes of death distribution,
accounting for stochastic uncertainty—ie, uncertainty that
arises when dealing with small numbers of observed
deaths. For example, if only ﬁve deaths were recorded in a
country, the underlying true cause of death distribution is
uncertain. The extent of uncertainty in cause of death
distribution for group A countries ranged from being
negligible for countries where a large number of deaths
were observed to substantial uncertainty for countries
where causes of death for only a small number of deaths
were recorded (eg, Belgium, where the causes of deaths
Abortion

for only ﬁve maternal deaths were recorded). For countries
with substantial uncertainty on the basis of a small
number of deaths, the hierarchical model informed the
country-speciﬁc estimate, whereas for countries with less
uncertainty, estimates were more data-driven and less
informed by the hierarchical model. For countries in
category B (where the recorded cause of death distributions
were available for a subset of maternal deaths from vital
registration or survey data), we assumed that the estimated
causes of death distributions from the recorded samples
were not necessarily representative of the causes of death
distributions of all maternal deaths in the period of
interest. For these countries, we assessed uncertainty in
the cause of death distribution estimates for all maternal
deaths without recorded causes on the basis of estimated
variability in, and correlation structure of, country-speciﬁc
cause of death distributions within regions. Therefore, the
ﬁnal estimated cause of death distributions for countries
in group B accounted for stochastic uncertainty and
additional uncertainty in the cause of death distributions
for the unrecorded subset of maternal deaths.
The estimation of the proportion of HIV/AIDS
maternal deaths was based on the approach used in the
estimation of the total number of maternal deaths.1,16
This approach provides country-speciﬁc estimates for the
proportion of HIV/AIDS maternal deaths among all
AIDS deaths to women of reproductive ages. These
country-speciﬁc estimates were combined with estimates

Embolism

Haemorrhage

Hypertension

Sepsis

Other direct causes

Indirect causes

N

% (95% UI)

N

% (95% UI)

N

% (95% UI)

N

% (95% UI)

N

% (95% UI)

N

% (95% UI)

N

% (95% UI)

193 000

7·9%
(4·7–13·2)

78 000

3·2%
(1·8–5·5)

661 000

27·1%
(19·9–36·2)

343 000

14·0%
(11·1–17·4)

261 000

10·7%
(5·9–18·6)

235 000

9·6%
(6·5–14·3)

672 000

27·5%
(19·7–37·5)

1100

7·5%
(5·7–11·6)

2000

2400

16·3
(11·1–24·6)

1900

12·9%
(10·0–16·8)

690

4·7%
(2·4–11·1)

2900

3600

24·7%
(19·5–33·9)

Developing regions 192 000

7·9%
(4·7–13·2)

76 000

3·1%
(1·7–5·4)

659 000

27·1%
(19·9–36·4)

341 000

14·0%
(11·1–17·4)

260 000

10·7%
(5·9–18·7)

232 000

9·6%
(6·4–14·3)

668 000

27·5%
(19·7–37·6)

490 2·2%
(0·9–4·9)

720

3·2%
(0·9–8·9)

8300

36·9%
(24·1–51·6)

3800

16·9%
(11·9–22·9)

1300

5·8%
(2·3–12·9)

3800

17·1%
(7·7–30·8)

4000

125 000 9·6%
(5·1–17·2)

27 000

2·1%
(0·8–4·5)

321 000

24·5%
(16·9–34·1)

209 000

134 000

10·3%
(5·5–18·5)

119 000

9·0%
(5·1–15·7)

375 000

28·6%
(19·9–40·3)

6500

11·5%
(1·6–40·6)

20 000

35·8%
(10·9–68·2)

5900

10·4%
(3·9–20·2)

1500

2·6%
(0·4–9·7)

8000

14·1%
(2·0–51·3)

14 000

24·9%
(6·4–58·8)

Worldwide
Developed regions

Northern Africa
Sub-Saharan Africa
Eastern Asia

420 0·8%
(0·2–2·0)

13·8%
(10·1–22·0)

16·0%
(11·7–21)

20·0%
(16·6–27·5)

18·0%
(9·5–30·2)

Southern Asia

47 000 5·9%
(1·5–17·3)

17 000

2·2%
(0·5–6·8)

238 000

30·3%
(14·0–54·8)

80 000

10·3%
(5·8–16·6)

107 000

13·7%
(3·3–35·9)

65 000

8·3%
(3·3–17·7)

229 000

29·3%
(12·2–55·1)

Southeastern Asia

11 000

18 000

12·1%
(3·2–33·4)

44 000

29·9%
(15·2–51·3)

21 000

14·5%
(8·4–22·7)

8100

5·5%
(1·8–15·0)

20 000

13·8%
(5·6–31·2)

25 000

16·8%
(7·8–34·2)

7·4%
(2·8–18·4)

Western Asia

860 3·0%
(1·0–7·6)

2600

9·2%
(3·3–22·6)

8900

30·7%
(17·4–49·1)

3900

13·4%
(7·5–21·2)

1400

4·8%
(1·5–13·1)

4500

15·6%
(6·6–33·7)

6700

23·4%
(11·3–43·1)

Caucasus and
central Asia

250 4·6%
(2·7–8·2)

590

10·9%
(6·2–18·2)

1200

22·8%
(17·2–30·3)

790

14·7%
(11·6–18·3)

460

8·5%
(5·7–13·6)

910

16·8%
(12·6–23·2)

1200

21·8%
(16·2–29·9)

Latin America
and Caribbean

6900 9·9%
(8·1–13·0)

2300

3·2%
(2·6–4·7)

16 000

23·1%
(19·7–27·8)

15 000

22·1%
(19·9–24·6)

5800

8·3%
(5·6–12·5)

10 000

14·8%
(11·7–19·4)

13 000

18·5%
(15·6–22·6)

610

14·8%
(1·9–47·6)

13·8%
(4·9–25·8)

200

5·0%
(0·6–18·5)

510

Oceania

290

7·1%
(1·2–22·9)

1200

29·5%
(8·5–61·7)

560

12·4%
(2·3–38·7)

710

17·4%
(4·7–44·3)

Data shown are the estimated proportion of cause of death (%) with 95% uncertainty interval (95% UI).

Table 1: Distribution of causes of deaths by Millennium Development Goal regions
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of the number of AIDS, maternal, and total deaths to
women of reproductive ages to obtain an initial mean
estimate for the proportion of HIV/AIDS maternal
deaths. These estimates were updated with countryspeciﬁc data on the proportion of HIV/AIDS deaths.
We used a Markov Chain Monte Carlo algorithm to
generate samples of the posterior distributions of all
model parameters, including the country-speciﬁc causes
of death distributions. Point estimates for proportions
were given by the posterior means of the proportion and
95% uncertainty intervals were given by the 2·5th and
97·5th percentiles of the posterior distributions. We
calculated the resulting distribution for each region from
the regional weighted averages of the estimated countryspeciﬁc cause of death distributions in the region.
Weights were based on the estimated number of maternal
deaths for each country for the year 2005 (which is the
estimation year closest to the midpoint of the study
period).1 The Markov Chain Monte Carlo sampling
algorithm was implemented in R (version 3.0.1) and JAGS
(version 3.3.0).17,18

Role of the funding source
The funder of the study had no role in study design, data
collection, data analysis, data interpretation, or writing of
the report. The corresponding author had full access to
all the data in the study and had ﬁnal responsibility for
the decision to submit for publication.

registration data, 29% from sub-Saharan Africa, and 2%
from southern Asia. Considering the total estimated
number of maternal deaths over 7 years, the study data
represents 2.5% of all maternal deaths in that period.4
Figure 2 shows the regional and global estimates of
distribution of causes of death. Nearly 73% of all maternal
deaths between 2003 and 2009 were due to direct obstetric
causes whereas deaths due to indirect causes accounted
for 27·5% (95% UI 19·7–37·5) of all deaths from known
causes (table 1). Haemorrhage was the leading direct
cause of maternal death worldwide, representing 27·1%
(19·9–36·2) of maternal deaths. More than two thirds of
reported haemorrhage deaths were classiﬁed as
postpartum haemorrhage (table 2). Hypertension was the
second most common direct cause worldwide (14·0%,
11·1–17·4). Maternal mortality due to sepsis was 10·7%
(5·9–18·6), abortion accounted for 7·9% (4·7–13·2), and
embolism and other direct causes accounted for the
remaining 12·8% of global deaths.
Table 3 shows the other direct causes of maternal
mortality. Complications of delivery were responsible
for 2·8% (1·6–4·9) and obstructed labour for 2·8%
(1·4–5·5) of all maternal deaths worldwide, both
reported within the other direct category, which
accounted for 9·6% of all maternal deaths worldwide.
Further breakdown of deaths due to indirect causes
suggests that more than 70% of indirect causes are

Results

Antepartum

Intrapartum

Postpartum

Haemorrhage total

Figure 1 summarises the identiﬁcation and selection of
data for incorporation into the model. We included vital
registration data from 79 countries, covering 338 countryyear datapoints during 2003–09, of which 263 (78%) came
from 58 countries with a good quality registration system.
Of the 50 179 citations identiﬁed from bibliographic
databases, 23 studies from 11 countries met the inclusion
criteria. Government reports, such as specialised statistical
tabulations and surveillance documents, were available for
a further 32 countries. These reports included “conﬁdential
enquiries”, ”RAMOS”, or specialised “maternal mortality
surveys”. Four countries (France, UK, South Africa, and
Mexico) produced conﬁdential enquiries or reports of
enhanced surveillance systems covering 12 country-years,
which were judged better than vital registration data for
that country. 26 datasets were informed by verbal autopsy;
however, only ten of these datasets speciﬁed the verbal
autopsy instrument used. The appendix shows further
details of source of data by country and the studies
providing the datasets.
All included data sources combined provided
417 datapoints from 115 countries and reported
62 378 deaths. Of these, we excluded 1579 deaths (2·5%),
almost exclusively from studies and governmental
reports, because no main cause of death could be
ascertained (appendix). Of the 60 799 maternal deaths
included in the ﬁnal database, 50% came from vital

N

%
(95% UI)

N

%
(95% UI)

N

%
(95% UI)

N

%
(95% UI)

Worldwide

158 000

6·5%
(4·3–9·6)

23 000

0·9%
(0·4–2·2)

480 000

19·7%
(12·9–28·9)

661 000

27·1%
(19·9–36·2)

Developed
regions

700

4·8%
(3·3–7·9)

510

Developing
regions

157 000

6·5%
(4·3–9·6)

23 000

720

3·2%
(1·5–6·2)

380
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Northern
Africa
Sub-Saharan
Africa

110 000

8·4%
(5·0–13·7)

12 000

Eastern Asia

3800

6·6%
(1·6–17·4)

Southern Asia

30 000

Southeastern
Asia

3·5%
(1·6–11·1)

1200

8·0%
(4·7–15·5)

2400

16·3%
(11·1–24·6)

0·9%
(0·4–2·2)

479 000

19·7%
(12·9–29)

659 000

27·1%
(19·9–36·4)

1·7%
(0·3–6·8)

7200

8300

36·9%
(24·1–51·6)

32·0%
(18·9–47·3)

0·9%
(0·2–3)

200 000

15·2%
(8·6–25·1)

321 000

24·5%
(16·9–34·1)

210

0·4%
(0·1–1·7)

16 000

28·7%
(6·1–63·9)

20 000

35·8%
(10·9–68·2)

3·8%
(1·5–8·5)

3400

0·4%
(0·1–1·5)

205 000

26·1%
(10·4–51·4)

238 000

30·3%
(14·0–54·8)

7000

4·7%
(2·0–10·7)

3100

2·1%
(0·3–8·7)

34 000

23·1%
(9·4–46·1)

44 000

29·9%
(15·2–51·3)

Western Asia

1700

6·0%
(2·9–11·7)

710

2·5%
(0·4–10·4)

6400

22·2%
(10·1–41·5)

8900

30·7%
(17·4–49·1)

Caucasus and
central Asia

280

5·2%
(3·5–7·9)

230

4·2%
(1·6–10·7)

720

13·4%
(9·4–19·8)

1200

22·8%
(17·2–30·3)

Latin America
and Caribbean

4000

5·8%
(4·5–7·8)

2900

4·1%
(2·1–9·0)

9200

13·3%
(10·9–16·4)

16 000

23·1%
(19·7–27·8)

200

4·8%
(1·0–13·8)

76

1·8%
(0·1–11·3)

940

22·9%
(4·1–57·8)

Oceania

1200

29·5%
(8·5–61·7)

Percentages shown are the subgroup as a proportion of all deaths for that region in the input dataset.

Table 2: Subgroup analysis of haemorrhage deaths by Millennium Development Goal region
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from pre-existing disorders, including HIV, when
exacerbated by pregnancy (table 4). HIV alone accounted
for 5·5% (3·8–7·6) of global maternal deaths.
The global distribution was aﬀected by the two regions,
sub-Saharan Africa and southern Asia, that accounted for
83·8% of all maternal deaths. Although estimated regional
cause of death distributions are quite uncertain for many
causes, point estimates show substantial diﬀerences
across regions (table 1 and ﬁgure 3). Haemorrhage
accounted for 36·9% (24·1–51·6) of deaths in northern
Africa, but only for 16·3% (11·1–24·6) in developed
regions. Hypertensive disorders were a particularly
important cause of death in Latin American and the
Caribbean, contributing to 22·1% (19·9–24·6) of all
maternal deaths in the region. Almost all sepsis deaths
were recorded in the developing countries, and the
proportion of such deaths was highest at 13·7% (3·3–35·9)
in southern Asia.
Only a small proportion of deaths are estimated to
result from abortion in eastern Asia (0·8%, 0·2–2·0),
where access to abortion is generally less restricted. Latin
America and the Caribbean, and sub-Saharan Africa
have a higher proportion of deaths in this category than
the global average; 9·9% (8·1–13·0) and 9·6% (5·1–17·2),
respectively. Another direct cause, embolism, accounted
for more deaths than its global average in southeastern
Asia (12·1%, 3·2–33·4) and eastern Asia (11·5%, 1·6–40·6).

Worldwide

Complications
of delivery

Obstructed labour

Other

N

N

%
(95% UI)

N

%
(95% UI)

N

%
(95% UI)

69 000

2·8
(1·4–5·5)

98 000

4
(2·2–7·5)

235 000

9·6
(6·5–14·3)

%
(95% UI)

68 000 2·8
(1·6–4·9)

Other direct
causes total

Developed
regions

760

5·2
(3·7–9·0)

94

0·6
(0·3–1·7)

2100

Developing
regions

67 000

2·8
(1·5–4·9)

69 000

2·9
(1·4–5·5)

96 000

1600

7·3
(2·9–15·9)

210

0·9
(0·2–3·3)

2000

8·8
(2·6–20·9)

Sub-Saharan
Africa

43 000

3·3
(1·5–6·7)

28 000

2·1
(0·7–5·2)

48 000

Eastern Asia

250

0·4
(0·1–1·4)

6900

12·3
(0·9–50·1)

770

Southern Asia 14 000

1·8
(0·4–5·2)

21 000

2·7
(0·5–8·5)

Southeastern
Asia

3000

2·1
(0·5–6·6)

9400

Western Asia

2000

7·1
(2·4–17·9)

Caucasus and
central Asia

400

7·3
(5·2–10·9)

Latin America
and Caribbean

2300
95

Northern
Africa

Oceania

14·1
(11·8–20·9)
3·9
(2·1–7·4)

2900 20
(16·6–27·5)
232 000

9·6
(6·4–14·3)

3800

17·1
(7·7–30·8)

3·7
(1·4–8·6)

119 000

9
(5·1–15·7)

1·4
(0·2–5·8)

8000

30 000

3·8
(0·9–10·3)

65 000

8·3
(3·3–17·7)

6·4
(1·4–20·6)

7800

5·3
(1·3–17·3)

20 000

13·8
(5·6–31·2)

320

1·1
(0·2–4·2)

2200

7·5
(2–23·2)

4500

15·6
(6·6–33·7)

47

0·9
(0·4–1·9)

460

8·6
(5·6–14·4)

3·3
(2·6–4·9)

3300

4·8
(3·2–8·3)

4700

6·7
(4·8–10·3)

10 000

2·3
(0·3–8·9)

210

5·1
(0·3–25·5)

210

5·1
(0·4–23·5)

510

14·1
(2–51·3)

910 16·8
(12·6–23·2)
14·8
(11·7–19·4)
12·4
(2·3–38·7)

Percentages shown are the subgroup as a proportion of all deaths for that region in the input dataset.
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The proportion of deaths due to indirect causes was
highest in southern Asia (29·3%, 12·2–55·1), followed by
sub-Saharan Africa (28·6%, 19·9–40·3). Indirect causes
also accounted for nearly a quarter of deaths in the
developed regions. The overall proportion of HIV
maternal deaths is highest in sub-Saharan Africa, 6·4%
(4·6–8·8%). The appendix shows estimates for countryspeciﬁc cause of death distributions.

Discussion
This systematic analysis suggests that indirect causes and
haemorrhage are the largest causes of maternal death
worldwide. Of the direct causes of death, haemorrhage
was the leading cause of maternal death, followed by
hypertensive disorders and sepsis. Regional estimates
varied substantially.
We scanned and included many data sources including
government reports and peer-reviewed scientiﬁc
literature (panel). Because of the paucity of data, all data
for a country were aggregated during the 7-year period
and model-based estimates were constructed for the
large subset of countries without any information about
their causes of death distributions. This approach diﬀers
from the previous WHO systematic review8 in which
recorded country-speciﬁc cause of death distributions
were weighted by the number of maternal deaths in the
country to obtain regional estimates. The new approach
was implemented to overcome the drawback of the
previous study that a recorded cause of death distribution
based on a small sample size in a country with a large
number of maternal deaths could unduly aﬀect the
regional estimates of the cause of death distribution. In
the estimation method applied in this study, countryspeciﬁc estimates of cause of death distribution were
informed by the available data in the country and the
regional average cause of death distribution, which can
be regarded as a typical pattern for the region (unweighted
by the total maternal death envelopes of the countries in
the region) through a Bayesian hierarchical model. The
accuracy of the regional and global estimates and 95%
uncertainty intervals were validated through two out-ofsample validation exercises and suggested satisfactory
model performance (appendix).
The diﬀerent analytical approaches of the previous
WHO review published in 2006 and the present analysis
limit our ability to make comparisons between the
ﬁndings of both. Furthermore, the limitations of the
dataset and the methods used in the previous study did
not allow for generation of a worldwide cause-of-death
estimate, and only estimates for large world regions were
calculated. However, some of the region-speciﬁc trends
reported in the previous analysis also seem to be found
in the present study. These include, for example, the
highest share of haemorrhage deaths in Asian regions,
the particular importance of hypertensive disorders of
pregnancy in Latin America and the Caribbean, and the
importance of indirect causes in sub-Saharan Africa.
www.thelancet.com/lancetgh Vol 2 June 2014
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Ultimately, the results of this analysis are constrained
by the accuracy of the data included. Cause of death data
are especially diﬃcult to analyse because of inadvertent
errors such as misclassiﬁcation and misinterpretation of
cause of death coding rules, or omissions or incorrect
entries because of the nature of some of the disorders
leading to maternal deaths such as abortion. We
recognise the limitations due to the particular issue of
misclassiﬁcation within maternal death certiﬁcation.
Although algorithms have been developed to adjust for
misclassiﬁcation of deaths in so-called garbage codes,32
such algorithms are not able to improve on misclassiﬁcation
within maternal cause categories or the under-reporting of
deaths of speciﬁc maternal causes. In view of the range of
classiﬁcation and under-reporting issues, and the limited
information available to accurately adjust data, we opted to
report aggregated cause of death fractions as reported in
good vital registration or as predicted by the model based
on unadjusted data. Therefore, resulting estimates should
be interpreted as the estimates for the reported cause of
death distribution.
An alternative estimation method was used more
recently in the GBD Study 2010 to obtain estimates for
the all-cause cause of death distribution, whereby a subset
of misclassiﬁcation issues were accounted for.9,33 The
GBD broad categorisation of causes of maternal death
diﬀered from our approach, with important diﬀerences
for some categories. For example, the GBD did not use a
category of indirect causes. Likewise, we included
obstructed labour as a subcategory of other direct causes,
in line with the ICD-MM, whereas the GBD study
regarded it as a main category.9 Inclusion of various
disorders within identiﬁed categories also diﬀered. For
example, long labour is included in the obstructed labour
category in our analysis, but not in the GBD study.
Nevertheless, broad agreement exists between our global
estimates and the GBD estimates (appendix).
However, estimates on maternal causes of death should
be viewed with caution. Although future research on
improved modelling approaches to deal with misclassiﬁcation errors might lead to improved estimates,
the absence of reliable data is a more pressing issue that
demands increased prioritisation.

Recommendations for policy and practice
Our results show two main concerns for policy and
practice related to data availability and quality in the
countries. First, where data are most needed, data are
often not available, which is unfortunately the case in
some countries with high mortality where estimates
were obtained on the basis of modelling. In this
analysis, India and Nigeria together accounted for a
third of global maternal deaths, but only one dataset
met criteria for inclusion (India). Of the ten countries
with the highest maternal mortality ratio in 2010, data
were available only for one, Cameroon. Moreover, only
5% of all deaths included in the analysis were from
www.thelancet.com/lancetgh Vol 2 June 2014

southern Asia where the second highest number of
maternal deaths were recorded. This means that cause
of death distribution in a region is aﬀected by the
countries that have data within that region. Although
the distribution is expected to be similar across
countries within a region, for some conditions where
availability of interventions signiﬁcantly vary because
of structural factors that are also highly contextual,
such as the legal status of abortion, diﬀerences are
expected.
Second, where data are available, they are often
incomplete. For example, we noted that indirect deaths
accounted for 27·5% (19·7–37·5) of deaths, although
the actual indirect causes were not well delineated in
more than a ﬁfth of the reported indirect maternal
deaths. Although it might be diﬃcult to establish with
certainty whether a woman’s pregnancy aggravated a
pre-existing medical disorder, or if their interaction
resulted in her death, improved documentation on the
sequence of events is paramount. For instance,
diﬀerentiation between indirect maternal deaths due to
HIV and direct maternal deaths in HIV-positive women
is important; this diﬀerence would have implications at
both clinical and programmatic levels. Accelerated
action is needed to improve data acquisition and quality,
especially relating to correct attribution of cause of
death information.
HIV-related

Pre-existing medical
conditions

Other indirect
causes

Indirect causes
total

N

N

N

N

%
(95% UI)

672 000

27·5%
(19·7–37·5)

3600

24·7%
(19·5–33·9)

%
(95% UI)

%
(95% UI)

Worldwide

134 000 5·5%
(3·8–7·6)

Developed
regions

400 2·7%
(1·0–5·1)

Developing
regions

133 000 5·5%
(3·8–7·7)

358 000 14·8
(9·1–23·5)

760 3·4%
(1·1–6·4)

2800 12·4
(5·3–24·1)

84 000 6·4%
(4·6–8·8)

168 000 12·8
(7·0–22·3)

Northern
Africa
Sub-Saharan
Africa
Eastern
Asia

361 000 14·8
(9·2–23·4)
3000 20·3
(16·1–29·1)

%
(95% UI)

177 000 7·2%
(3·5–14·6)
250

1·7%
(0·9–4·4)

177 000 7·3%
(3·5–14·7)
500

2·2%
(0·6–7·2)

122 000 9·3%
(4·6–18·4)

668 000 27·5%
(19·7–37·6)
4000

18·0%
(9·5–30·2)

375 000

28·6%
(19·9–40·3)

0·2%
(0·0–1·1)

14 000

24·9%
(6·4–58·8)

6·3%
(0·5–25·3)

229 000

29·3%
(12·2–55·1)

2200 3·9%
(0·3–10·6)

12 000 20·7
(3·5–54·4)

130

Southern Asia

37 000 4·8%
(1·2–10·2)

143 000 18·2
(6·1–41·9)

49 000

Southeastern
Asia

5900 4·0%
(1·4–8·3)

17 000 11·8
(4·1–28·7)

1400

1·0%
(0·2–3·5)

25 000

16·8%
(7·8–34·2)

Western Asia

1200 4·2%
(1·5–8·4)

4900 16·9
(6·5–36·5)

650

2·2%
(0·5–8·1)

6700

23·4%
(11·3–43·1)

Caucasus and
Central Asia

130 2·3%
(1·0–4·1)

920 16·9
(11·9–24·7)

140

2·5%
(1·4–5·1)

1200

21·8%
(16·2–29·9)

Latin America
and Caribbean

1300 1·8%
(0·9–3·0)

9800 14·0
(11·7–17·6)

1800

2·6%
(1·9–4·5)

13 000

18·5%
(15·6–22·6)

170 4·2%
(0·5–11·1)

500 12·3%
(1·9–38·2)

36

0·9%
(0·1–4·4)

710

Oceania

17·4%
(4·7–44·3)

Percentages shown are the subgroup as a proportion of all deaths for that region in the input dataset.
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Comparison of causes across regions
Dev
N Africa
SSA
E Asia
S Asia
SE Asia
W Asia
CC Asia
LAC
Oceania

ABO

EMB

HEM

HYP

SEP

DIR

IND

0

5

10

15

20
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25

30

35

40

Figure 3: Estimates for main causes of death by region
Point estimates are shown by bars (and squares) and 95% uncertainty intervals
are shown by the horizontal lines. ABO=abortion. EMB=embolism.
HEM=haemorrhage. HYP=hypertension. SEP=sepsis. DIR=direct causes.
IND=indirect causes. Dev=developed regions. N Africa=northern Africa.
SSA=sub-Saharan Africa. E Asia=eastern Asia. S Asia=southern Asia.
SE Asia=southeastern Asia. W Asia=western Asia. CC Asia=Caucasus and central
Asia. LAC=Latin America and the Caribbean.
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We included several sources of cause of death data, the
quality of which depends on who completed the death
certiﬁcate or verbal autopsy, who interpreted the
information from the death certiﬁcate or verbal autopsy,
and whether medical records were available for review to
conﬁrm or revise the ascertained cause of death.
Conﬁdential enquires and special maternal death reviews
can provide such information, but the feasibility of doing
such detailed reviews is very restricted.
To support data acquisition and quality needs, revisions
are being made to the standard verbal autopsy instrument
to increase the feasibility of its implementation where
cause of death attribution is possible only by those
means. Furthermore, the ICD-MM will standardise
documentation and analysis related to maternal causes
of death and their attribution to direct and indirect
causes.14 Discrepancies exist in how some deaths are
categorised. For example, suicide in some contexts is
regarded as coincidental whereas in other settings it
might be reported within direct or indirect maternal
deaths. Maternal suicides are known to happen in the
context of undesired pregnancy, inability to access
abortion, and postpartum depression or psychosis. ICDMM suggests that maternal suicides will be included
within the direct category of maternal death. With the
process for the 11th revision of the ICD well underway,34
one can anticipate the possibility for improved granularity
of data. But one must also recognise the responsibility of
the certifying professional to provide accurate and useful
information for improved epidemiological monitoring
and assessment to inform policies with the best available
evidence. Calls for inclusion of training on cause of death
certiﬁcation and the use of ICD use within medical
curricula are well founded and should be supported.
Still, these calls for better data need to acknowledge the
realities in establishing, with accuracy, what the cause of
death was at time of certiﬁcation. This need for accuracy
is especially important in relation to identiﬁcation of
indirect maternal deaths that aim to establish the
aggravating eﬀect between the physiological eﬀects of
pregnancy and another disease.
With regard to clinical implications, we ﬁnd that, despite
established interventions to prevent and treat postpartum
haemorrhage (eg, active management of the third stage of
labour35), haemorrhage remains the leading individual
cause of death. With available data, it is not possible to
establish whether the persistence of haemorrhage as the
leading cause of death despite eﬀective interventions is
the result of a failure to implement such interventions,
whether there is a shift towards antepartum haemorrhage
or a shift in delivery practice such as increasing rates of
caesarean sections, or whether misclassiﬁcations with
regard to abortion and obstructed labour are erroneously
increasing the haemorrhage category.
Further analysis to elucidate the separate contribution of
antepartum and postpartum causes will have important
implications for the planning and implementation of policy
www.thelancet.com/lancetgh Vol 2 June 2014
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Panel: Misclassiﬁcation and underreporting issues by cause of death
Abortion
We estimated that 7·9% (95% UI 4·7–13·2) of all maternal deaths were due to
abortion. This ﬁnding is lower than the previous assessments, which estimated
mortality due to unsafe abortion at 13%.19,20 Classiﬁcation of maternal deaths
due to abortion, and more speciﬁcally unsafe abortion, is associated with a risk
of misclassiﬁcation, which might lead to underreporting. Even where induced
abortion is legal, religious and cultural perceptions in many countries mean that
women do not disclose abortion attempts and relatives or health-care
professionals do not report deaths as such. Under-registration of deaths might
be the result of stigmatisation of abortion aﬀecting what information is
reported by relatives and informants or intentional misclassiﬁcation by
providers when abortion is restricted.21
In these circumstances, the overall number of maternal mortality might not be
aﬀected, whereas abortion-related deaths might be particularly underestimated
because of this under-reporting. Although these abortion-related deaths might be
classiﬁed mainly into sepsis and haemorrhage, this might over-simplify the
complexity of death reporting. An analysis22 comparing International
Classiﬁcation of Diseases 10 (ICD-10) codes for underlying cause of death with the
remainder of information about the death certiﬁcate and verbal autopsy in rural
Mexico found that deaths due to second trimester abortion were misclassiﬁed
into both maternal and non-maternal deaths. Examples of misclassiﬁcation
included assigning underlying cause of death from amniotic ﬂuid embolism to
cerebral anoxia, rather than abortion, either induced or spontaneous. Validation
studies like this provide needed insight into the quality and accuracy of maternal
mortality data. However, short of reviewing every death certiﬁcate and medical
record after the death of a woman aged 15–49 years, the study further highlights
the diﬃculty associated with considering adjustments to account for this type of
misclassiﬁcation, or indeed any misclassiﬁcation. Validation studies can identify
patterns of systematic or unbalanced misclassiﬁcation, but the validity of
application of adjustment parameters derived by verbal autopsy data from one
location to another, and application of factors from hospital-based studies to
population-based data, can be problematic.23
Obstructed labour
Deaths that happen after obstructed labour and its consequences are hard to
measure because they can be coded as uterine rupture, haemorrhage, or sepsis.
This is especially problematic in settings where verbal autopsies are used to
establish cause of death. Verbal autopsy methods do not have consistent case
deﬁnitions, which creates confusion regarding hierarchical assignment of
causes and subsequently aﬀects the validity of the study data.24 A speciﬁc
mention is warranted to clarify the classiﬁcation of obstructed labour in this
study, which is subsumed into direct causes of death, following guidance from
ICD-MM.14 Although from a clinical perspective, obstructed labour is commonly
understood as a phenomenon by which a woman might die in labour, from an
epidemiological and classiﬁcation standpoint, it is inappropriate to identify
obstructed labour as a cause of death.

and programmes, because interventions to address them
are very diﬀerent. Although the international community
has rightly focused on postpartum haemorrhage, and
speciﬁcally atonic postpartum haemorrhage, it is now the
appropriate time to unpack the obstetric haemorrhage
category. The improved method used in this analysis
allowed delineation of haemorrhage deaths, reporting that
www.thelancet.com/lancetgh Vol 2 June 2014

The ICD-10 aims to capture the initiating step most relevant to public health in
the sequence leading to death, because preventing this disorder would prevent
not just the death, but all of the illness, complications, and disability that
preceded it. In these cases of obstructed labour, death might be prevented by
access to operative delivery. However, when the only available information
from a lay reporter suggests that the woman seemed to be in labour, or in
pain, for a long time before death, little is actually known about the sequence
of events that leads to death, or about the progress of labour. These deaths
might be misattributed to obstructed labour, leading to overestimation of the
proportion that could be prevented through operative delivery and
underestimation of the need for other services. In most settings, the
implementation of ICD-10 coding does not allow dual coding for cause of
death—eg, obstructed labour and sepsis, or obstructed labour with uterine
rupture and haemorrhage. Proposals for the ICD-11 revision link the disorders,
thereby satisfying the need for clinicians to document obstructed labour while
ascertaining the cause of death.
Indirect causes of death (excluding HIV/AIDS)
The phenomenon of misattribution of indirect maternal causes of death,
resulting in underestimation of 20−90% of maternal deaths, has been
described in a number of settings.25–30 In Austria, misclassiﬁcation was
signiﬁcantly higher for indirect deaths (81%, 95% CI 64−91) than direct
deaths (28%, 21−36),31 whereas in the UK, indirect deaths accounted for up to
74% of under-reported maternal deaths during 2003–05.30
HIV/AIDS
Under-reporting and misclassiﬁcation of indirect maternal deaths due to HIV/
AIDS are especially problematic. Although verbal autopsy might be able to
measure AIDS mortality,43 hospital data-based validation studies might not be
useful in adjusting for the eﬀect of misclassiﬁcation error in the estimates of
cause-speciﬁc mortality fractions at the population level.23
When deaths happen in a facility, death certiﬁcate reporting might show
only HIV as a cause of death and not an obstetric complication such as sepsis.
This situation highlights the need for speciﬁc review of deaths of women
infected with HIV temporal to pregnancy. The woman might die from HIV or
with HIV while pregnant. Since 2010, this distinction is now possible from
the standpoint of statistical tabulation as per ICD-10 coding. Our analyses
precede the changes in ICD-10 coding and so a decision was made to
consider cases where HIV was listed as a cause of maternal death, whether by
description or use of a B code, as an indirect maternal death. As these data
are scarce, the proportion of indirect maternal deaths due to HIV is probably
underestimated in this study. It is anticipated that as methods for global
maternal death estimation evolve, evidence of the parameters needed to
estimate indirect maternal HIV deaths and further clariﬁcation on the use of
ICD-10 codes will standardise and improve our understanding of maternal
and HIV death tallies.14

about 24·0% of all haemorrhage deaths happened during
pregnancy, and the remainder in the intrapartum or
postpartum period. Thus we provide for the ﬁrst time an
evidence-based estimation of the proportion of maternal
deaths due to antepartum haemorrhage.
Also alarming is the proportion of deaths attributed to
hypertensive disorders, which are the second highest
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worldwide among all direct causes and the most
prominent cause in the Latin America and Caribbean
region. This ﬁnding is despite the well established
evidence that magnesium sulphate more than halves the
risk of death from pre-eclampsia.36–39 Although magnesium
sulphate is deemed an essential drug by WHO,40 the
problem is the extent to which it is available and
appropriately used in most countries. A systematic review
on the prevalence of pre-eclampsia and eclampsia
described the barriers to the use of magnesium sulphate
as drug licensing and availability, inadequate and poorly
implemented clinical guidelines, and insuﬃcient political
support for policy change.41 More recently, a WHO survey 42
of delivery care in more than 300 health facilities in
29 countries highlighted that, even if coverage of
magnesium sulphate is high in cases where coverage is
needed, the overall mortality due to eclampsia was not
reduced, highlighting the fact that more attention to other
elements of quality of care is also needed.
The large proportion of deaths attributed to indirect
causes cannot be ignored. As direct maternal deaths
decrease because of targeted interventions, eﬀorts to
reduce maternal mortality will have to be refocused on
reduction of indirect causes. Although emphasis has been
placed on linking maternal and HIV care, addressing the
needs of women with pre-existing comorbid disorders
such as cardiac and endocrine disease in pregnancy will
need additional links between obstetric and other medical
specialties. This situation is further complicated as the
burden of non-communicable diseases is high in
developing countries where health systems are poorly
equipped to coordinate specialised care. The four main
non-communicable diseases are cardiovascular diseases,
cancers, diabetes, and chronic respiratory diseases.43
Among these diseases, diabetes, cardiovascular,
respiratory disorders, and cancers are of particular concern
among reproductive aged women for their potential
contribution as indirect causes for both morbidity and
mortality. Further focus on understanding the true
burden of these disorders in pregnancy, and on the
changing demographics of disease patterns, is warranted.
The gaps in coverage of eﬀective interventions, for both
direct and indirect causes of deaths, according to their
distribution in various settings have large implications in
view of the urgent need to accelerate the rate of decrease
in maternal mortality to reach the MDG5 target and
further to end all preventable maternal deaths.44 Therefore,
accurate and routine information about causes of maternal
deaths is crucial in both implementation of interventions
and tracking and interpretation of the gaps in coverage.
Contributors
LS and AMG conceived the review. All authors developed the methods.
A-BM did the literature search and prepared the vital registration data.
AB-M, DC, and JPD considered studies for inclusion and extracted the
data. LA developed the statistical model and did the statistical analysis. All
authors provided input to the interpretation of the results. LS, OT, DC, and
LA prepared the manuscript and supplementary material. All authors
provided input to the manuscript and approved the ﬁnal version.

e332

Declaration of interests
Five WHO staﬀ members (LS, DC, ÖT, AMG, and MT) are part of the
team that did the study. The ﬁndings in this paper represent the
conclusions of the authors. We declare that we have no further
competing interests.
Acknowledgments
We thank Andrew Howman and Rita Champaneria for their assistance
with the literature searching and data management; the Child Health
Epidemiology Reference Group (CHERG) for their technical review;
Cristina Cuesta, Gilda Piaggio, Zoe Matthews, and Colin Mathers for their
advice on the statistical methods; and Alexandra Furmston, Lixia Dou,
Naomi Lee, Celia Liu, João Paulo Dias De Souza, Roderik F Viergever,
Karmela Krleža-Jerić Irena Zakarija-Grkovic, and the Croatian Branch of
the Italian Cochrane Centre for their assistance with translating reports
for this study.
References
1
WHO, UNICEF, UNFPA, The World Bank. Trends in maternal
mortality: 1990 to 2010. WHO, UNICEF, UNFPA, and The World
Bank Estimates, 2012.
2
United Nations. United Nations Millennium Development Goals.
2013. http://www.un.org/millenniumgoals/maternal.shtml
(accessed Feb 28, 2014).
3
United Nations’ Secretary General. Global Strategy for Women’s
and Children’s Health. New York: United Nations, 2010.
4
WHO, UNICEF, UNFPA, The World Bank. Trends in maternal
mortality: 1990 to 2008. WHO, UNICEF, UNFPA, and The World
Bank Estimates, 2010.
5
Hogan MC, Foreman KJ, Naghavi M, et al. Maternal mortality for
181 countries, 1980–2008: a systematic analysis of progress towards
Millennium Development Goal 5. Lancet 2010; 375: 1609–23.
6
Wilmoth J, Mathers C, Say L, Mills S. Maternal deaths drop by
one-third from 1990 to 2008: a United Nations analysis.
Bull World Health Organ 2010; 88: 718.
7
WHO. International Classiﬁcation of Diseases and Related Health
Problems. Geneva: World Health Organization, 1992.
8
Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF.
WHO analysis of causes of maternal death: a systematic review.
Lancet 2006; 367: 1066–74.
9
Lozano R, Naghavi M, Foreman K, et al. Global and regional
mortality from 235 causes of death for 20 age groups in 1990 and
2010: a systematic analysis for the Global Burden of Disease Study
2010. Lancet 2012; 380: 2095–128.
10 United Nations. Millenium Development Indicators: world and
regional groupings. http://mdgs.un.org/unsd/mdg/Host.
aspx?Content=Data/RegionalGroupings.htm (accessed Feb 28, 2014).
11 WHO. WHO mortality database: tables. 2010. http://www.who.int/
healthinfo/morttables.
12 Gulmezoglu AM, Say L, Betran AP, Villar J, Piaggio G.
WHO systematic review of maternal mortality and morbidity:
methodological issues and challenges. BMC Med Res Method 2004; 4: 16.
13 WHO. ICD-10 translator. http://www.icd10data.com/Convert
(accessed April 30, 2014).
14 WHO. The WHO Application of ICD-10 to deaths during pregnancy,
childbirth and the puerperium: ICD-MM, 2012.
15 WHO, UNICEF, UNFPA, The World Bank. Trends in maternal
mortality: 1990 to 2010. World Health Organization, UNICEF,
UNFPA, and The World Bank, 2012.
16 Wilmoth JR, Mizoguchi N, Oestergaard MZ, et al. A new method
for deriving global estimates of maternal mortality.
Stat Politics Policy 2012; 3: 1038.
17 R Development Core Team. R: A Language and Environment for
Statistical Computing. Vienna, Austria: R Foundation for Statistical
Computing, 2011.
18 Plummer M. JAGS: A Program for Analysis of Bayesian Graphical
Models Using Gibbs Sampling. Proceedings of the 3rd International
Workshop on Distributed Statistical Computing (DSC 2003); 2003;
Vienna, Austria; 2003.
19 Abouzahr C, Royston E. Maternal mortality: a global factbook.
Geneva: World Health Organization, 1991.
20 Ahman E, Shah IH. New estimates and trends regarding unsafe
abortion mortality. Int J Gynaecol Obstet 2011; 115: 121–26.

www.thelancet.com/lancetgh Vol 2 June 2014

Articles

21

22

23

24

25

26

27

28

29

30

31

32

Gerdts C, Vohra D, Ahern J. Measuring unsafe abortion-related
mortality: a systematic review of the existing methods. PloS one
2013; 8: e53346.
Walker D, Campero L, Espinoza H, et al. Deaths from
complications of unsafe abortion: misclassiﬁed second trimester
deaths. Reprod Health Matters 2004; 12: 27–38.
Chandramohan D, Setel P, Quigley M. Eﬀect of misclassiﬁcation of
causes of death in verbal autopsy: can it be adjusted? Int J Epidemiol
2001; 30: 509–14.
Leitao J, Chandramohan D, Byass P, et al. Revising the WHO verbal
autopsy instrument to facilitate routine cause-of-death monitoring.
Glob Health Action 2013; 6: 21518.
Bouvier-Colle MH, Varnoux N, Costes P, Hatton F. Reasons for the
underreporting of maternal mortality in France, as indicated by a
survey of all deaths among women of childbearing age.
Int J Epidemiol 1991; 20: 717–21.
Deneux-Tharaux C, Berg C, Bouvier-Colle MH, et al.
Underreporting of pregnancy-related mortality in the United States
and Europe. Obstet Gynecol 2005; 106: 684–92.
Kao S, Chen LM, Shi L, Weinrich MC. Underreporting and
misclassiﬁcation of maternal mortality in Taiwan.
Acta Obstet Gynecol Scand 1997; 76: 629–36.
Karimian-Teherani D, Haidinger G, Waldhoer T, Beck A, Vutuc C.
Under-reporting of direct and indirect obstetrical deaths in Austria,
1980-98. Acta Obstet Gynecol Scand 2002; 81: 323–27.
Schuitemaker N, Van Roosmalen J, Dekker G, Van Dongen P,
Van Geijn H, Gravenhorst JB. Underreporting of maternal
mortality in The Netherlands. Obstet Gynecol 1997; 90: 78–82.
Centre for Maternal and Child Enquiries. Conﬁdential enquiry into
maternal and child health. Saving mothers’ lives: reviewing
maternal deaths to make motherhood safer 2003–2005. The
Seventh Report of the Conﬁdential Enquiries into Maternal Deaths
in the United Kingdom. Dec, 2007. http://www.publichealth.hscni.
net/sites/default/ﬁles/Saving%20Mothers’%20Lives%20200305%20.pdf (accessed April 15, 2014).
Lopman B, Cook A, Smith J, et al. Verbal autopsy can consistently
measure AIDS mortality: a validation study in Tanzania and
Zimbabwe. J Epidemiol Community Health 2010; 64: 330–34.
Naghavi M, Makela S, Foreman K, O’Brien J, Pourmalek F,
Lozano R. Algorithms for enhancing public health utility of
national causes-of-death data. Popul Health Met 2010; 8: 9.

www.thelancet.com/lancetgh Vol 2 June 2014

33

34

35
36
37

38

39

40

41

42

43

44

Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability
(YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010:
a systematic analysis for the Global Burden of Disease Study 2010.
Lancet 2012; 380: 2163–96.
WHO. The International Classiﬁcation of Diseases 11th Revision is
due by 2017. http://www.who.int/classiﬁcations/icd/revision/en/
(accessed Feb 28, 2014).
WHO. WHO recommendations for the prevention and treatment of
postpartum haemorrhage. Geneva: World Health Organization, 2012.
Duley L, Gulmezoglu AM, Chou D. Magnesium sulphate versus lytic
cocktail for eclampsia. Cochrane Database Syst Rev 2010; 9: CD002960.
Duley L, Gulmezoglu AM, Henderson-Smart DJ, Chou D.
Magnesium sulphate and other anticonvulsants for women with
pre-eclampsia. Cochrane Database Syst Rev 2010; 11: CD000025.
Duley L, Henderson-Smart DJ, Chou D. Magnesium sulphate
versus phenytoin for eclampsia. Cochrane Database Syst Rev 2010;
10: CD000128.
Duley L, Henderson-Smart DJ, Walker GJ, Chou D. Magnesium
sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev
2010; 12: CD000127.
WHO. WHO Model List of Essential Medicines, 2013. http://www.
who.int/medicines/publications/essentialmedicines/en/ (accessed
April 29, 2014).
Aaserud M, Lewin S, Innvaer S, et al. Translating research into policy
and practice in developing countries: a case study of magnesium
sulphate for pre-eclampsia. BMC Health Serv Res 2005; 1: 68.
Souza JP, Gulmezoglu AM, Vogel J, et al. Moving beyond essential
interventions for reduction of maternal mortality (the WHO
Multicountry Survey on Maternal and Newborn Health):
a cross-sectional study. Lancet 2013; 381: 1747–55.
WHO. Global status report on noncommunicable diseases 2010,
2011. http://www.who.int/nmh/publications/ncd_report2010/en/
(accessed April 30, 2014).
Bustreo F, Say L, Koblinsky M, Pullum TW, Temmerman M,
Pablos-Mendez A. Ending preventable maternal deaths: the time is
now. Lancet Glob Health 2013; 1: 176–77.

e333

